CD43 抗体 (PE)
Quick Overview for CD43 抗体 (PE) (ABIN135775)
抗原
See all CD43 (SPN) 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
特异性
- Human CD43, Mr 95-135 kDa
-
产品特性
- Mouse Anti-Human CD43-PE
-
免疫原
- KG-1 cells
-
亚型
- IgG1
-
-
-
-
应用备注
-
- Applications: FC - Quality tested , IHC-FS - Reported in literature , IHC-PS - Reported in literature , ICC - Reported in literature , IP - Reported in literature , WB - Reported in literature , Adhesion - Reported in literature
- Working Dilutions: Flow Cytometry Purified (UNLB) antibody 1 g/106 cells FITC, BIOT, PE, APC, and SPRD conjugates 10 L/106 cells For flow cytometry, the suggested use of these reagents is in a final volume of 100 L
-
限制
- 仅限研究用
-
-
-
缓冲液
- 100 tests in 1.0 mL of PBS/Sodium azide and a stabilizing agent
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
注意事项
-
Do not freeze!
Protect conjugated products from light.
Each reagent is stable for the period shown on the bottle label if stored as directed. -
储存条件
- 4 °C
-
储存方法
- Store at 2-8°C
-
-
-
: "Defining patients as palliative: hospital doctors' versus general practitioners' perceptions." in: Palliative medicine, Vol. 16, Issue 3, pp. 247-50, (2002) (PubMed).
-
: "Defining patients as palliative: hospital doctors' versus general practitioners' perceptions." in: Palliative medicine, Vol. 16, Issue 3, pp. 247-50, (2002) (PubMed).
-
- CD43 (SPN) (Sialophorin (SPN))
-
别名
- CD43
-
背景
- CD43, a member of the sialomucin family of cell surface receptors, is a 95-135 kDa type I transmembrane glycoprotein whose variability in molecular weight is dependent upon the nature of the extracellular O-glycans. It is the major sialoglycoprotein on thymocytes, T cells and neutrophils. It is also present on activated B cells, plasma cells, NK cells, granulocytes, monocytes, macrophages, platelets and bone marrow hematopoietic stem cells. CD43, which binds to ICAM-1 (CD54), appears to function as an anti-adhesion molecule, inhibiting T cell interactions, including T cell killing, and by increasing the threshold for T cell activation.
-
途径
- Regulation of Leukocyte Mediated Immunity
抗原
-